These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6118024)

  • 1. Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock.
    Lefer AM; Lefer DJ; Levin RJ
    Adv Shock Res; 1980; 3():167-74. PubMed ID: 6118024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta adrenoceptor blocking properties of MK-761.
    Sweet CS; Hall RA; Columbo JM; Wenger HC; Backlund E; Morgan G; Gaul SL; Scriabine A
    J Pharmacol Exp Ther; 1979 Oct; 211(1):195-9. PubMed ID: 40012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
    Freeman JG; Hock CE; Edmonds JS; Lefer AM
    J Pharmacol Exp Ther; 1984 Dec; 231(3):610-5. PubMed ID: 6094795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock.
    Curtis MT; Lefer AM
    Circ Shock; 1983; 10(2):131-45. PubMed ID: 6301706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer AM
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat.
    Trachte GJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):309-20. PubMed ID: 677964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
    Curtis MT; Lefer AM
    Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective actions of nafazatrom in traumatic shock.
    Lefer AM; Messenger M
    Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dopamine on liver dynamics in hemorrhagic shock.
    Trachte GJ; Lefer AM
    Circ Shock; 1977; 4(4):305-15. PubMed ID: 598004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic blockade reduces skeletal muscle glycolysis and Na(+), K(+)-ATPase activity during hemorrhage.
    McCarter FD; James JH; Luchette FA; Wang L; Friend LA; King JK; Evans JM; George MA; Fischer JE
    J Surg Res; 2001 Aug; 99(2):235-44. PubMed ID: 11469892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial actions of a free radical scavenger in traumatic shock and myocardial ischemia.
    Lefer AM; Araki H; Okamatsu S
    Circ Shock; 1981; 8(3):273-82. PubMed ID: 7249259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J; Hock CE; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective action of timolol in acute myocardial ischemia.
    Lefer AM; Cohn JR; Osman GH
    Eur J Pharmacol; 1977 Feb; 41(4):379-85. PubMed ID: 14835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
    Hock CE; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDF: its participation in the pathophysiology of shock.
    Okada K; Kosugi I; Tanokura Y; Tajimi K; Ohmura A; Innami H; Tsukamoto T; Inaba T
    Prog Clin Biol Res; 1983; 111():125-46. PubMed ID: 6867021
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure.
    Katori T; Hoover DB; Ardell JL; Helm RH; Belardi DF; Tocchetti CG; Forfia PR; Kass DA; Paolocci N
    Circ Res; 2005 Feb; 96(2):234-43. PubMed ID: 15591228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor blocking drugs and the glaucoma suspect.
    Langham ME
    Ann Ophthalmol; 1981 Mar; 13(3):273. PubMed ID: 6114701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.